GEHC in the 13F filings
Ge Healthcare Technologies I · CUSIP 36266G107
- Quarter end
- 31 Mar 2025
- the date the book describes
- Filed
- 15 May 2025
- latest of these filings; the earliest 2 May 2025
- Managers listing it
- 18
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q4 2024 and Q1 2025; 13 listed it in both
- Shares listed
- 103,869,232
- combined, among listed positions
- Reported value
- $8.4bn
- combined, at the quarter end
Among the 95 comparable managers: 9 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing GEHC in Q1 2025
18 of 18 holders
Largest increases and reductions, by shares
Increases
- Harris Associates LPexisting position · 5,633,942 shares now+1,386,638
- Holocene Advisors LPexisting position · 1,445,830 shares now+1,146,954
- Freestone Grove Partners LPnew position · 745,839 shares now+745,839
- Farallon Capital Management LLCexisting position · 537,000 shares now+413,000
- Renaissance Technologies LLCnew position · 392,600 shares now+392,600
Reductions
- Capital Research Global Investorsexisting position · 51,195,068 shares now-9,636,936
- T. Rowe Price Associates Incexisting position · 2,966,334 shares now-3,198,337
- D1 Capital Partners LPexisting position · 1,249,584 shares now-2,237,000
- Steadfast Capital Management LPexisting position · 553,347 shares now-302,728
- AllianceBernstein LPexisting position · 5,958,708 shares now-168,961
New positions and exits
New (3)
Exited (3)
- Egerton Capital UK LLPwas $357m
- Discovery Capital Management LLCwas $3.9m
- PDT Partners LLCwas $2.3m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2022 | 1 | $371m | n.a. | n.a. |
| Q1 2023 | 13 | $8.0bn | n.a. | n.a. |
| Q2 2023 | 21 | $8.7bn | n.a. | n.a. |
| Q3 2023 | 14 | $6.6bn | n.a. | n.a. |
| Q4 2023 | 13 | $7.3bn | 7 | 8 |
| Q1 2024 | 17 | $9.7bn | 10 | 5 |
| Q2 2024 | 17 | $8.0bn | 9 | 5 |
| Q3 2024 | 20 | $10.7bn | 9 | 11 |
| Q4 2024 | 18 | $8.8bn | 10 | 6 |
| Q1 2025 | 18 | $8.4bn | 9 | 11 |
| Q2 2025 | 22 | $7.2bn | 15 | 6 |
| Q3 2025 | 14 | $6.3bn | 6 | 9 |
| Q4 2025 | 13 | $8.1bn | 17 | 22 |
| Q1 2026 | 11 | $6.3bn | 19 | 18 |
| Q2 2026 | 9 | $4.9bn | 24 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
GEHC and LLY →GEHC and JNJ →GEHC and VRTX →Choose a stock to compare with GEHC →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own GEHC, latest filings →Back to the 13F Explorer →